Payne Joseph E Insider Trades

Insider Trading History

Track insider trading activity for Payne Joseph E. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Arcturus Therapeutics Holdings
Arcturus Therapeutics Holdings ARCT
President And CEO
Holding Value $1.33M 175,000 shares
Last Trade
Dec 17, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.14M 175,000 shares
$6.52
$7.60
Arcturus Therapeutics Holdings
Arcturus Therapeutics Holdings ARCT
President And CEO
Holding Value $1.49M 196,000 shares
Last Trade
Dec 16, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.18M 196,000 shares
$16.24
$7.60
Arcturus Therapeutics Holdings
Arcturus Therapeutics Holdings ARCT
President And CEO
Holding Value $1.52M 200,000 shares
Last Trade
Dec 15, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.78M 200,000 shares
$28.88
$7.60
Arcturus Therapeutics Holdings
Arcturus Therapeutics Holdings ARCT
President And CEO
Holding Value $1.9M 250,000 shares
Last Trade
Dec 09, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.23M 250,000 shares
$16.92
$7.60
Arcturus Therapeutics Holdings
Arcturus Therapeutics Holdings ARCT
President And CEO
Holding Value $11.2M 1,480,097 shares
Last Trade
Nov 23, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$82.6k 5,000 shares
$16.51
$7.60
Arcturus Therapeutics Holdings
Arcturus Therapeutics Holdings ARCT
President And CEO
Holding Value $1.14M 150,000 shares
Last Trade
Jun 21, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.18M 150,000 shares
$14.56
$7.60
Vallon Pharmaceuticals
Vallon Pharmaceuticals VLON
Director
Holding Value $3k 7,500 shares
Last Trade
Jun 09, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.83k 7,500 shares
$0.51
$0.40
GRI Bio
GRI Bio GRI
Director
Holding Value $15.1k 7,500 shares
Last Trade
Jun 09, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$178M 7,500 shares
$23,669.10
$2.01
GRI Bio
GRI Bio GRI
Director
Holding Value $35.2k 17,500 shares
Last Trade
May 26, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.38B 6,800 shares
$202,347.60
$2.01
Vallon Pharmaceuticals
Vallon Pharmaceuticals VLON
Director
Holding Value $7k 17,500 shares
Last Trade
May 26, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$30.6k 6,800 shares
$4.50
$0.40
Vallon Pharmaceuticals
Vallon Pharmaceuticals VLON
Director
Holding Value $4.28k 10,700 shares
Last Trade
May 25, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$41.2k 10,700 shares
$3.85
$0.40
GRI Bio
GRI Bio GRI
Director
Holding Value $21.5k 10,700 shares
Last Trade
May 25, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$2.06B 10,700 shares
$192,137.40
$2.01
GRI Bio
GRI Bio GRI
Director
Holding Value $28.7k 14,286 shares
Last Trade
May 14, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.97B 29,286 shares
$169,860.60
$2.01
Vallon Pharmaceuticals
Vallon Pharmaceuticals VLON
Director
Holding Value $6k 15,000 shares
Last Trade
May 14, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$107k 29,286 shares
$3.66
$0.40
Arcturus Therapeutics Holdings
Arcturus Therapeutics Holdings ARCT
10% owner, President And CEO
Holding Value $1.33M 175,000 shares
Last Trade
Dec 18, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$17.4M 175,000 shares
$99.29
$7.60
Arcturus Therapeutics Holdings
Arcturus Therapeutics Holdings ARCT
President And CEO
Holding Value $11.2M 1,475,097 shares
Last Trade
Jun 10, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$31.7k 1,000 shares
$31.69
$7.60
Arcturus Therapeutics Holdings
Arcturus Therapeutics Holdings ARCT
10% owner, President And CEO
Holding Value $760k 100,000 shares
Last Trade
Feb 18, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.41M 100,000 shares
$14.12
$7.60
Arcturus Therapeutics Holdings
Arcturus Therapeutics Holdings ARCT
10% owner, President And CEO
Holding Value $11.2M 1,474,097 shares
Last Trade
Aug 29, 2019 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$56.1k 5,000 shares
$11.22
$7.60

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up